Literature DB >> 6213997

Concanavalin A-induced suppressor cell activity and in vitro immunoglobulin secretion in rheumatoid arthritis: correlation with clinical and immunological parameters.

J S Smolen, G Lanzer, O Scherak, E J Menzel, W R Mayr, C Steffen, W Knapp.   

Abstract

Concanavalin A-induced suppressor cell activity was found moderately but significantly (P less than 0.05) decreased in RA patients treated with nonsteroidal antiinflammatory drugs (31 +/- 7% suppression) as compared to patients on remission-inducing drugs, such as gold, penicillamine, or chloroquine (51 +/- 6%) or to healthy individuals (50 +/- 6%). Also, lymphocytes from patients with antibodies to collagen mediated lower suppression (33 +/- 7%) than lymphocytes from patients without evidence for these autoantibodies (61 +/- 11%). No significant difference between patients and controls or between individual groups of patients were observed in regard to IgM and IgG secretion induced by pokeweed mitogen. Thus, although no indication for a severe derangement of regulatory cells in peripheral blood of RA patients could be observed in this study, a slight deficiency of ConA-inducible suppressor cells that may be reverted by remission-inducing drugs seems to be present in RA.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6213997     DOI: 10.1007/bf00541255

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  36 in total

1.  B-lymphocyte alloantigens associated with systemic lupus erythematosus.

Authors:  J L Reinertsen; J H Klippel; A H Johnson; A D Steinberg; J L Decker; D L Mann
Journal:  N Engl J Med       Date:  1978-09-07       Impact factor: 91.245

2.  Monocyte-mediated suppression of human B lymphocyte differentiation in vitro.

Authors:  W Knapp; G Baumgartner
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

Review 3.  The immunopathology of joint inflammation in rheumatoid arthritis.

Authors:  N J Zvaifler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

4.  Impaired immunoglobulin synthesis by peripheral blood lymphocytes in systemic lupus erythematosus.

Authors:  K M Nies; J S Louie
Journal:  Arthritis Rheum       Date:  1978 Jan-Feb

5.  Prevalence of HLA-DRw2 not increased in systemic lupus erythematosus.

Authors:  O Scherak; J S Smolen; W R Mayr
Journal:  N Engl J Med       Date:  1979-09-13       Impact factor: 91.245

6.  Circulating suppressor cells in man as a function of age.

Authors:  J P Antel; M Weinrich; B G Arnason
Journal:  Clin Immunol Immunopathol       Date:  1978-01

7.  Direct evidence for loss of human suppressor cells during active autoimmune disease.

Authors:  A J Strelkauskas; R T Callery; J McDowell; Y Borel; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

8.  Immunoglobulin synthesis by peripheral blood cells in systemic lupus erythematosus.

Authors:  H E Jasin; M Ziff
Journal:  Arthritis Rheum       Date:  1975 May-Jun

9.  Demonstration of anticollagen antibodies in rheumatoid arthritis synovial fluids by 14C-radioimmunoassay.

Authors:  J Menzel; C Steffen; G Kolarz; M Kojer; J Smolen
Journal:  Arthritis Rheum       Date:  1978-03

10.  Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

Authors:  L Shou; S A Schwartz; R A Good
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  3 in total

1.  Impaired release of a T-cell specific suppressor factor in rheumatoid arthritis.

Authors:  C Lau; S Budz-Tymkewycz; M Ramsden; P Lee; E C Keystone
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

2.  Spontaneous and aggregated IgG induced rheumatoid factor producing cells in rheumatoid arthritis.

Authors:  E J Pisko; R A Turner; M Panetti; S L Foster; E Heise
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

3.  The role of Ia positive T cells in patients with rheumatoid arthritis.

Authors:  K Kato; J Okada; S Kashiwazaki
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.